QS vs OTLC: Which is Better to Buy in 2026?

Side-by-side fundamental comparison based on AI analysis of SEC filings

AI Verdict

QS has stronger fundamentals based on our AI analysis.

QS
QuantumScape Corp
SELL
75%
Confidence
VS
OTLC
Oncotelic Therapeutics, Inc.
STRONG SELL
95%
Confidence

QS vs OTLC Fundamental Comparison

Metric QS OTLC
Revenue N/A $70,000.0
Net Income $-435.1M $-1.1M
Net Margin N/A -1,526.0%
ROE -37.2% -11.8%
ROA -33.3% -3.8%
Current Ratio 15.95x 0.08x
Debt/Equity 0.00x 0.14x
EPS $-0.76 $0.00

Green = Better metric | Red = Weaker metric

View Full QS Analysis →
View Full OTLC Analysis →
Browse Sectors: Technology Healthcare Finance Energy Consumer Industrial
Stock Lists: Strong Buy Undervalued Growth Dividend

You Might Also Compare

QS vs AAPL OTLC vs MSFT QS vs GOOGL OTLC vs AMZN

QS vs OTLC: Frequently Asked Questions

Is QS or OTLC a better buy in 2026?

Based on dual AI fundamental analysis (Claude and ChatGPT), QS has stronger fundamentals. QS is rated SELL (75% confidence) while OTLC is rated STRONG SELL (95% confidence). This is not investment advice.

How does QS compare to OTLC fundamentally?

QuantumScape Corp has ROE of -37.2% vs Oncotelic Therapeutics, Inc.'s -11.8%. Net margins are N/A vs -1,526.0% respectively.

Which stock pays higher dividends, QS or OTLC?

QS has a dividend yield of N/A or no dividend while OTLC has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.

Should I invest in QS or OTLC for long term?

For long-term investing, consider that QS has SELL rating with 75% confidence, while OTLC has STRONG SELL rating with 95% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.

What do the AI models say about QS vs OTLC?

Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For QS vs OTLC, the AI consensus favors QS based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.